DOCSLIB.ORG

Maresin 1 Biosynthesis During Platelet–Neutrophil Interactions Is Organ-Protective

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Maresin 1 Biosynthesis During Platelet–Neutrophil Interactions Is Organ-Protective Maresin 1 biosynthesis during platelet–neutrophil interactions is organ-protective Raja-Elie E. Abdulnoura,1, Jesmond Dallib,1, Jennifer K. Colbya, Nandini Krishnamoorthya, Jack Y. Timmonsa, Sook Hwa Tana, Romain A. Colasb, Nicos A. Petasisc, Charles N. Serhanb, and Bruce D. Levya,b,2 aPulmonary and Critical Care Medicine and bCenter for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; and cDepartment of Chemistry, University of Southern California, Los Angeles, CA 90089 Edited by Derek William Gilroy, University College London, London, United Kingdom, and accepted by the Editorial Board October 10, 2014 (received for review April 17, 2014) Unregulated acute inflammation can lead to collateral tissue injury 12-lipoxygenase that may be capable of generating the 13S,14S- in vital organs, such as the lung during the acute respiratory distress epoxy-maresin intermediate and participating in MaR1 production syndrome. In response to tissue injury, circulating platelet–neutro- at sites of vascular inflammation. Here, we provide evidence for phil aggregates form to augment neutrophil tissue entry. These a MaR1 biosynthetic route during platelet–neutrophil interactions early cellular events in acute inflammation are pivotal to timely that is operative in vivo in a murine model of ARDS to restrain resolution by mechanisms that remain to be elucidated. Here, we inflammation and restore homeostasis of the injured lung. identified a previously undescribed biosynthetic route during hu- man platelet–neutrophil interactions for the proresolving mediator Results maresin 1 (MaR1; 7R,14S-dihydroxy-docosa-4Z,8E,10E,12Z,16Z,19Z- To determine if platelets can participate in vascular MaR1 bio- hexaenoic acid). Docosahexaenoic acid was converted by platelet synthesis, platelets were isolated from fresh human whole blood, 12-lipoxygenase to 13S,14S-epoxy-maresin, which was further trans- then incubated with d5-DHA in the presence or absence of au- formed by neutrophils to MaR1. In a murine model of acute respira- tologous peripheral blood neutrophils, and activated with either tory distress syndrome, lipid mediator metabololipidomics uncovered platelet-activating factor (PAF) or the platelet-specific agonist MaR1 generation in vivo in a temporally regulated manner. Early thrombin. MaR1 biosynthesis was assessed by lipid mediator MEDICAL SCIENCES MaR1 production was dependent on platelet–neutrophil interactions, (LM) metabololipidomics (SI Methods). Small amounts of MaR1 and intravascular MaR1 was organ-protective, leading to decreased – lung neutrophils, edema, tissue hypoxia, and prophlogistic mediators. were identified in platelet d5-DHA incubations by matching MS/ A B Together, these findings identify a transcellular route for intravascular MS fragmentation patterns and retention times (Fig. 1 and ). maresin 1 biosynthesis via platelet–neutrophil interactions that regu- Coincubation of platelets with neutrophils in the presence of lates the extent of lung inflammation. PAF markedly increased MaR1 generation (Fig. 1A) in a neu- trophil-dependent manner (Fig. 1C); platelet activation with maresin | platelet | inflammation | lung | resolution PAF (Fig. 1A) or thrombin (Fig. 1C) or increased platelet ne critical function of acute inflammatory responses is de- Significance Olivery of leukocytes to sites of tissue injury to protect the host and restore homeostasis (1, 2). Activated vascular endo- Neutrophil accumulation is fundamental to acute inflammation. In thelial cells recruit leukocytes by direct interaction (primary response to tissue injury, circulating neutrophil–platelet aggre- capture) or via platelets (secondary capture) that engage circu- gates (N-PAs) form for secondary capture. Counterregulation of lating leukocytes rapidly after tissue injury (3, 4). If excessive, acute inflammatory processes by specialized proresolving medi- leukocyte recruitment and activation can injure healthy host ators is essential to mitigate collateral injury to healthy bystander bystander tissues and cause organ damage (2, 5)—a pathobiology tissue. Here, we identified a biosynthetic route in human platelets common to several diseases, including the acute respiratory for the proresolving mediator maresin 1 (MaR1) that is amplified distress syndrome (ARDS), a devastating condition of acute lung during platelet–neutrophil interactions. In a self-resolving murine inflammation with excess morbidity and mortality and without model of acute lung injury, N-PAs rapidly formed and a MaR1 available medical therapy (6). Platelet–neutrophil interactions counterregulatory circuit was engaged to restrain N-PAs and are integral to the early inflammatory response in ARDS (7, 8). acute inflammation and restore homeostasis of the injured lung. In health, acute inflammatory responses are terminated by Author contributions: R.E.A., J.D., C.N.S., and B.D.L. designed research; R.E.A., J.D., J.K.C., specialized proresolving mediators (SPMs) that restrain the in- N.K., J.Y.T., S.H.T., R.A.C., C.N.S., and B.D.L. performed research; N.A.P. contributed new flammatory response and signal for resolution (2). Early cellular reagents/analytic tools; R.E.A., J.D., N.K., R.A.C., C.N.S., and B.D.L. analyzed data; and and biochemical events in acute inflammation are pivotal to R.E.A., J.D., J.K.C., N.K., J.Y.T., S.H.T., R.A.C., N.A.P., C.N.S., and B.D.L. wrote the paper. timely resolution (9, 10). A new family of SPMs of macrophage Conflict of interest statement: C.N.S. is an inventor on patents (resolvins) assigned to origin was recently uncovered in murine peritonitis and human Brigham and Women’s Hospital (BWH) and licensed to Resolvyx Pharmaceuticals. C.N.S. was the scientific founder of Resolvyx Pharmaceuticals and owns founder stock in the macrophages and coined maresins (macrophage mediators in re- company. C.N.S.’s interests were reviewed and are managed by the Brigham and solving inflammation) (11). Maresins are biosynthesized via initial Women’s Hospital and Partners HealthCare in accordance with their conflict of in- lipoxygenation and molecular oxygen insertion at the carbon 14 terest policies. B.D.L. is an inventor on patents (resolvins) assigned to BWH and licensed to position of docosahexaenoic acid (DHA) followed by epoxi- Resolvyx Pharmaceuticals. B.D.L.’s interests were reviewed and are managed by the Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict dation and oxygen incorporation at the carbon 7 position from of interest policies. amoleculeofH2O (11). The complete stereochemistry of maresin This article is a PNAS Direct Submission. D.W.G. is a guest editor invited by the Editorial 1 (MaR1; 7R,14S-dihydroxy-docosa-4Z,8E,10E,12Z,16Z,19Z-hex- Board. aenoic acid) (12) and its biosynthesis via a 13S,14S-epoxy-maresin 1R.E.A. and J.D. contributed equally to this work. intermediate (13S,14S-epoxy-docosa-4Z,7Z,9E,11E,16Z,19Z-hex- 2To whom correspondence should be addressed. Email: [email protected]. aenoic acid) (13) were recently established. In addition to mac- This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. rophages, human and murine platelets contain arachidonate 1073/pnas.1407123111/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1407123111 PNAS Early Edition | 1of6 Downloaded by guest on September 29, 2021 ACB d -MaR1 364 5 100 175 * * PA F 221 Thrombin 100 D 250 H+ 141 Neutrophils and Platelets D D H+ 150 D OH OH D H+ 113 neutrophils) 125 * 6 COO- 100 75 d5-MaR1 50 Platelets 302 m/z 346 Relative Abundance (%) Relative Abundance (%) 364>250 25 221 250 284 141 177 320 364>250 113 206 232 328 0 (pg/5x10 production-MaR1 0 5 0 2 4 6 8 101214161820 22 100 140 180 220 260 300 340 380 d 1:1 1:5 1:10 Time (min) m/z, Da Neutrophil to Platelet ratio DEF G 359 100 100 100 x 5.0 4 Neutrophils MaR1 Neutrophils MaR1 plus plus 221 141 * O 250 H+ + 3 OOH 109 H COOH OH OH COO 315 14S-HpDHA 13S,14S-epoxy-maresin H+113 2 297 COO- 323 331 1 Relative Abundance (%) Abundance Relative MaR1 (pg/ml) MaR1 Relative Abundance (%) Relative Abundance (%) 161.2 277 341 109 141 221232 113 177 279 206 250 0 0 0 2.0 4.0 6.0 8.0 10.012.014.0 16.018.0 20.0 22.0 0 2.0 4.0 6.0 8.0 10.012.014.0 16.018.0 20.0 22.0 100 140 180 220 260 300 340 380 IgG Psel-Ab Time (min) Time (min) m/z, Da Fig. 1. MaR1 is produced by N-PAs via transcellular biosynthesis. (A–C) MaR1 production by isolated human peripheral blood platelets incubated with d5- DHA before incubation with or without neutrophils in the presence of PAF or thrombin. Levels of d5-MaR1 were assessed by liquid chromatography (LC)–MS/MS metabololipidomics. (A) Representative multiple reaction monitoring (MRM) chromatograms (m/z = 364–250) and (B) MS/MS spectrum from PAF-treated samples used for the identification of d5-MaR1. (C)d5-MaR1 levels in incubations with different neutrophil-to-platelet ratios. Results for A and B are rep- resentative of n = 3 healthy donor blood isolations. Results for C are mean ± SEM for n = 3 healthy donor blood isolations. *P < 0.05. (D–F) Human peripheral blood neutrophils were isolated by density centrifugation. Cells were suspended at 1 × 108 in PBS with 10 mg/mL BSA, then incubated with (D)10μM 14HpDHA or (E)10μM 13S,14S-eMaR and 0.1 mg of serum-treated zymosan (15 min, 37 °C, pH 7.45). (F) Representative MS/MS spectrum used for the identification of MaR1 (7R,14S-dihydroxydocosa-4Z,8E,10E,12Z,16Z,19Z-hexaenoic acid). (G) Levels of MaR1 in fresh human whole blood pretreated with anti-human P-selectin or isotype control antibody after treatment with PAF (500 nM).
Load more

Recommended publications
  • Eicosanoids in Carcinogenesis
    4open 2019, 2,9 © B.L.D.M. Brücher and I.S. Jamall, Published by EDP Sciences 2019 https://doi.org/10.1051/fopen/2018008 Special issue: Disruption of homeostasis-induced signaling and crosstalk in the carcinogenesis paradigm “Epistemology of the origin of cancer” Available online at: Guest Editor: Obul R. Bandapalli www.4open-sciences.org REVIEW ARTICLE Eicosanoids in carcinogenesis Björn L.D.M. Brücher1,2,3,*, Ijaz S. Jamall1,2,4 1 Theodor-Billroth-Academy®, Germany, USA 2 INCORE, International Consortium of Research Excellence of the Theodor-Billroth-Academy®, Germany, USA 3 Department of Surgery, Carl-Thiem-Klinikum, Cottbus, Germany 4 Risk-Based Decisions Inc., Sacramento, CA, USA Received 21 March 2018, Accepted 16 December 2018 Abstract- - Inflammation is the body’s reaction to pathogenic (biological or chemical) stimuli and covers a burgeoning list of compounds and pathways that act in concert to maintain the health of the organism. Eicosanoids and related fatty acid derivatives can be formed from arachidonic acid and other polyenoic fatty acids via the cyclooxygenase and lipoxygenase pathways generating a variety of pro- and anti-inflammatory mediators, such as prostaglandins, leukotrienes, lipoxins, resolvins and others. The cytochrome P450 pathway leads to the formation of hydroxy fatty acids, such as 20-hydroxyeicosatetraenoic acid, and epoxy eicosanoids. Free radical reactions induced by reactive oxygen and/or nitrogen free radical species lead to oxygenated lipids such as isoprostanes or isolevuglandins which also exhibit pro-inflammatory activities. Eicosanoids and their metabolites play fundamental endocrine, autocrine and paracrine roles in both physiological and pathological signaling in various diseases. These molecules induce various unsaturated fatty acid dependent signaling pathways that influence crosstalk, alter cell–cell interactions, and result in a wide spectrum of cellular dysfunctions including those of the tissue microenvironment.
    [Show full text]
  • Effects of Maresin 1, an Omega-3 Fatty Acid-Derived Lipid Mediator, on Adipose Tissue and Liver Function in Obesity [Tesis Docto
    Facultad de Farmacia y Nutrición Effects of Maresin 1, an omega-3 fatty acid-derived lipid mediator, on adipose tissue and liver function in obesity Efectos de Maresina 1, un mediador lipídico derivado de los ácidos grasos omega-3, en la función del tejido adiposo y el hígado en obesidad Laura Laiglesia González Pamplona, 2017 Facultad de Farmacia y Nutrición Memoria presentada por Dña. Laura Laiglesia González para aspirar al grado de Doctor por la Universidad de Navarra. Fdo. Laura Laiglesia González El presente trabajo ha sido realizado bajo nuestra dirección en el Departamento de Ciencias de la Alimentación y Fisiología de la Facultad de Farmacia y Nutrición de la Universidad de Navarra y autorizamos su presentación ante el Tribunal que lo ha de juzgar. VºBº Directora VºBº Co-Directora María Jesús Moreno Aliaga Silvia Lorente Cebrián Este trabajo ha sido posible gracias a la financiación de diversas entidades: Gobierno de España (Ministerio de Economía, Industria y Competitividad) [BFU2012-36089 y BFU2015-65937-R], Gobierno de Navarra (Departamento de Salud) [67-2015], Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERObn) Instituto de Salud Carlos III (ISCIII) [CB12/03/30002], Centro de Investigación en Nutrición (Universidad de Navarra). Beca predoctoral 2013-2017: La investigación que ha dado lugar a estos resultados ha sido impulsada por la Obra Social "la Caixa” y la Asociación de Amigos de la Universidad de Navarra. Acknowledgements Me gustaría expresar mi agradecimiento a esas personas que han hecho posible la realización de este trabajo durante los últimos cuatro años, hasta aquellos que me han escuchado a pesar de no entender muy bien que es lo que estaba haciendo.
    [Show full text]
  • Reduced 15-Lipoxygenase 2 and Lipoxin A4/Leukotriene B4 Ratio in Children with Cystic Fibrosis
    ORIGINAL ARTICLE CYSTIC FIBROSIS Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis Fiona C. Ringholz1, Paul J. Buchanan1, Donna T. Clarke1, Roisin G. Millar1, Michael McDermott2, Barry Linnane1,3,4, Brian J. Harvey5, Paul McNally1,2 and Valerie Urbach1,6 Affiliations: 1National Children’s Research Centre, Crumlin, Dublin, Ireland. 2Our Lady’s Children’s Hospital, Crumlin, Dublin, Ireland. 3Midwestern Regional Hospital, Limerick, Ireland. 4Centre for Interventions in Infection, Inflammation and Immunity (4i), Graduate Entry Medical School, University of Limerick, Limerick, Ireland. 5Molecular Medicine Laboratories, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland. 6Institut National de la Sante´ et de la Recherche Me´dicale, U845, Faculte´ de Me´decine Paris Descartes, Paris, France. Correspondence: Valerie Urbach, National Children’s Research Centre, Crumlin, Dublin 12, Ireland. E-mail: [email protected] ABSTRACT Airway disease in cystic fibrosis (CF) is characterised by impaired mucociliary clearance, persistent bacterial infection and neutrophilic inflammation. Lipoxin A4 (LXA4) initiates the active resolution of inflammation and promotes airway surface hydration in CF models. 15-Lipoxygenase (LO) plays a central role in the ‘‘class switch’’ of eicosanoid mediator biosynthesis from leukotrienes to lipoxins, initiating the active resolution of inflammation. We hypothesised that defective eicosanoid mediator class switching contributes to the failure to resolve inflammation in CF lung disease. Using bronchoalveolar lavage (BAL) samples from 46 children with CF and 19 paediatric controls we demonstrate that the ratio of LXA4 to leukotriene B4 (LTB4) is depressed in CF BAL (p,0.01), even in the absence of infection (p,0.001).
    [Show full text]
  • Strict Regio-Specificity of Human Epithelial 15-Lipoxygenase-2
    Strict Regio-specificity of Human Epithelial 15-Lipoxygenase-2 Delineates its Transcellular Synthesis Potential Abigail R. Green, Shannon Barbour, Thomas Horn, Jose Carlos, Jevgenij A. Raskatov, Theodore R. Holman* Department Chemistry and Biochemistry, University of California Santa Cruz, 1156 High Street, Santa Cruz CA 95064, USA *Corresponding author: Tel: 831-459-5884. Email: [email protected] FUNDING: This work was supported by the NIH NS081180 and GM56062. Abbreviations: LOX, lipoxygenase; h15-LOX-2, human epithelial 15-lipoxygenase-2; h15-LOX-1, human reticulocyte 15-lipoxygenase-1; sLO-1, soybean lipoxygenase-1; 5-LOX, leukocyte 5-lipoxygenase; 12-LOX, human platelet 12-lipoxygenase; GP, glutathione peroxidase; AA, arachidonic acid; HETE, hydoxy-eicosatetraenoic acid; HPETE, hydroperoxy-eicosatetraenoic acid; diHETEs, dihydroxy-eicosatetraenoic acids; 5-HETE, 5-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid; 5-HPETE, 5-hydro peroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid; 12-HPETE, 12-hydroperoxy-5Z,8Z,10E, 14Z-eicosatetraenoic acid; 15-HPETE, 15-hydroperoxy-5Z,8Z,10Z,13E- eicosatetraenoic acid; 5,15-HETE, 5S,15S-dihydroxy-6E,8Z,10Z,13E-eicosatetraenoic acid; 5,15-diHPETE, 5,15-dihydroperoxy-6E,8Z,10Z,13E-eicosatetraenoic acid; 5,6- diHETE, 5S,6R-dihydroxy-7E,9E,11Z,14Z-eicosatetraenoic acid; LTA4, 5S-trans-5,6- oxido-7E,9E,11Z,14Z-eicosatetraenoic acid; LTB4, 5S,12R-dihydroxy-6Z,8E,10E,14Z- eicosatetraenoic acid; LipoxinA4 (LxA4), 5S,6R,15S-trihydroxy-7E,9E,11Z,13E- eicosatetraenoic acid; LipoxinB4 (LxB4), 5S,14R,15S-trihydroxy-6E,8Z,10E,12E- eicosatetraenoic acid. Abstract Lipoxins are an important class of lipid mediators that induce the resolution of inflammation, and arise from transcellular exchange of arachidonic acid (AA)- derived lipoxygenase products.
    [Show full text]
  • Role of Epigallocatechin, Resveratrol and Curcumin As Anti-Inflammatory and Anti-Tumoral Agents
    Open Access International Journal of Nutritional Sciences Review Article Role of Epigallocatechin, Resveratrol and Curcumin as Anti-Inflammatory and Anti-Tumoral Agents Giordano F, Mauro L, Naimo GD and Panno ML* Department of Pharmacy, Health and Nutritional Abstract Sciences, University of Calabria, Italy Inflammatory microenvironment plays a critical role in tumorigenesis *Corresponding author: Panno ML, Department of process as well as in chemoresistance. In response to tissue injury, inflammatory Pharmacy, Health and Nutritional Sciences, University of cytokines help to start and maintain carcinogenesis over time. Epidemiological Calabria, Cubo 4C, Via ponte P. Bucci, 87040 Arcavacata investigations have shown that the consumption of polyphenol-rich food reduces di Rende, Cosenza, Italy the oxidative cellular damage and in such way, it can exert protective effects against degenerative diseases and cancers. In addition, these compounds Received: March 01, 2018; Accepted: April 09, 2018; reduce proliferation, trigger apoptosis, modulate signal transduction and have Published: April 20, 2018 anti-inflammatory action. In this review we have focused the study on three polyphenolic compound-derivatives (EGCG, RES, CUR), going to show the molecular mechanism through which they antagonize the cancer – associated inflammation and the stem-cell chemoresistance. Keywords: Polyphenols; Chemoresistance; Inflammation; Citokines Introduction ancient times. Today, they represent a valid alternative, especially in some conditions, since many products, due to technological The assumption that the “right nutrition” keeps a healthy life is innovation, are meticulously studied and tested in their biological quite known and mostly reiterated in traditional medicine. In recent effects at the cellular and molecular level. This has made their use years, natural compounds are getting increasing interest suggesting more targeted and successful.
    [Show full text]
  • Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators On
    antioxidants Review Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation 1, 1,2, 2, Gyeoung Jin Kang y, Eun Ji Kim y and Chang Hoon Lee * 1 Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455, USA; [email protected] (G.J.K.); [email protected] (E.J.K.) 2 College of Pharmacy, Dongguk University, Seoul 04620, Korea * Correspondence: [email protected]; Tel.: +82-31-961-5213 Equally contributed. y Received: 11 November 2020; Accepted: 9 December 2020; Published: 10 December 2020 Abstract: Heart disease is the number one mortality disease in the world. In particular, cardiac fibrosis is considered as a major factor causing myocardial infarction and heart failure. In particular, oxidative stress is a major cause of heart fibrosis. In order to control such oxidative stress, the importance of nuclear factor erythropoietin 2 related factor 2 (NRF2) has recently been highlighted. In this review, we will discuss the activation of NRF2 by docosahexanoic acid (DHA), eicosapentaenoic acid (EPA), and the specialized pro-resolving lipid mediators (SPMs) derived from polyunsaturated lipids, including DHA and EPA. Additionally, we will discuss their effects on cardiac fibrosis via NRF2 activation. Keywords: cardiac fibrosis; NRF2; lipoxins; resolvins; maresins; neuroprotectins 1. Introduction Cardiovascular disease is the leading cause of death worldwide [1]. Cardiac fibrosis is a major factor leading to the progression of myocardial infarction and heart failure [2]. Cardiac fibrosis is characterized by the net accumulation of extracellular matrix proteins in the cardiac stroma and ultimately impairs cardiac function [3]. Therefore, interest in substances with cardioprotective activity continues.
    [Show full text]
  • The Effects of Curcumin, Mangiferin, Resveratrol and Other Natural Plant
    The effects of curcumin, mangiferin, resveratrol and other natural plant products on aminopeptidase B activity Sandrine Cadel, Cécile Darmon, Alexandre Désert, Mouna Mahbouli, Christophe Piesse, Thanos Ghélis, René Lafont, Thierry Foulon To cite this version: Sandrine Cadel, Cécile Darmon, Alexandre Désert, Mouna Mahbouli, Christophe Piesse, et al.. The effects of curcumin, mangiferin, resveratrol and other natural plant products on aminopeptidase B activity. Biochemical and Biophysical Research Communications, Elsevier, 2019, 512 (4), pp.832-837. 10.1016/j.bbrc.2019.02.143. hal-02189376 HAL Id: hal-02189376 https://hal.sorbonne-universite.fr/hal-02189376 Submitted on 19 Jul 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. The effects of curcumin, mangiferin, resveratrol and other natural plant products on aminopeptidase B activity * Sandrine Cadel a, ,Cecile Darmon a, Alexandre Desert a, Mouna Mahbouli a, Christophe Piesse b, Thanos Ghelis a,Rene Lafont a, Thierry Foulon a a Sorbonne Universite, Institut de Biologie Paris Seine (IBPS), Equipe Biogenese des Signaux Peptidiques (BIOSIPE), 75005, Paris, France b Sorbonne Universite, CNRS, Institut de Biologie Paris Seine (IBPS), Plate-forme Ingenierie des Proteines et Synthese Peptidique, 75005, Paris, France abstract þ Aminopeptidase B (Ap-B) is a Zn2 -aminopeptidase of the M1 family which is implicated, in conjunction with the nardilysin endoprotease, in the generation of miniglucagon, a peptide involved in the main- tenance of glucose homeostasis.
    [Show full text]
  • Maresin 1 Promotes Inflammatory Resolution, Neuroprotection and Functional Neurological Recovery After Spinal Cord Injury
    This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. Research Articles: Development/Plasticity/Repair Maresin 1 promotes inflammatory resolution, neuroprotection and functional neurological recovery after spinal cord injury Isaac Francos Quijorna1, Eva Santos-Nogueira1, Karsten Gronert2, Aaron B. Sullivan2, Marcel A Kopp3, Benedikt Brommer3,4, Samuel David5, Jan M. Schwab3,6,7 and Ruben Lopez Vales1 1Departament de Biologia Cel·lular, Fisiologia i Immunologia, Institut de Neurociències, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, 08193 Bellaterra, Catalonia Spain 2Vision Science Program, School of Optometry, University of California Berkeley, Berkeley, CA 94598, USA 3Spinal Cord Alliance Berlin (SCAB) and Department of Neurology and Experimental Neurology, Charité Campus Mitte, Clinical and Experimental Spinal Cord Injury Research Laboratory (Neuroparaplegiology), Charité-Universitätsmedizin Berlin, Berlin, Germany 4F.M. Kirby Neurobiology Center, Boston Children's Hospital, and Department of Neurology, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA 5Centre for Research in Neuroscience, The Research Institute of the McGill University Health Centre, Montreal, Canada 6Department of Neurology, Spinal Cord Injury Division, The Neurological Institute, The Ohio State University, Wexner Medical Centre, Columbus, OH 43210, USA 7Department of Neuroscience and Center for Brain and Spinal Cord Repair, Department of Physical Medicine and Rehabilitation, The Neurological Institute, The Ohio State University, Wexner Medical Centre, Columbus, OH 43210, USA. DOI: 10.1523/JNEUROSCI.1395-17.2017 Received: 22 May 2017 Revised: 27 September 2017 Accepted: 1 October 2017 Published: 3 November 2017 Author contributions: I.F.Q., J.S., and R.L.-V.
    [Show full text]
  • Inflammation, Cancer and Oxidative Lipoxygenase Activity Are Intimately Linked
    Cancers 2014, 6, 1500-1521; doi:10.3390/cancers6031500 OPEN ACCESS cancers ISSN 2072-6694 www.mdpi.com/journal/cancers Review Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked Rosalina Wisastra and Frank J. Dekker * Pharmaceutical Gene Modulation, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +31-5-3638030; Fax: +31-5-3637953. Received: 16 April 2014; in revised form: 27 June 2014 / Accepted: 2 July 2014 / Published: 17 July 2014 Abstract: Cancer and inflammation are intimately linked due to specific oxidative processes in the tumor microenvironment. Lipoxygenases are a versatile class of oxidative enzymes involved in arachidonic acid metabolism. An increasing number of arachidonic acid metabolites is being discovered and apart from their classically recognized pro-inflammatory effects, anti-inflammatory effects are also being described in recent years. Interestingly, these lipid mediators are involved in activation of pro-inflammatory signal transduction pathways such as the nuclear factor κB (NF-κB) pathway, which illustrates the intimate link between lipid signaling and transcription factor activation. The identification of the role of arachidonic acid metabolites in several inflammatory diseases led to a significant drug discovery effort around arachidonic acid metabolizing enzymes. However, to date success in this area has been limited. This might be attributed to the lack of selectivity of the developed inhibitors and to a lack of detailed understanding of the functional roles of arachidonic acid metabolites in inflammatory responses and cancer.
    [Show full text]
  • Maresin 1 Activates LGR6 Receptor Promoting Phagocyte Immunoresolvent Functions
    Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions Nan Chiang, … , Xavier de la Rosa, Charles N. Serhan J Clin Invest. 2019;129(12):5294-5311. https://doi.org/10.1172/JCI129448. Research Article Inflammation Graphical abstract Find the latest version: https://jci.me/129448/pdf RESEARCH ARTICLE The Journal of Clinical Investigation Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions Nan Chiang, Stephania Libreros, Paul C. Norris, Xavier de la Rosa, and Charles N. Serhan Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA. Resolution of acute inflammation is an active process orchestrated by endogenous mediators and mechanisms pivotal in host defense and homeostasis. The macrophage mediator in resolving inflammation, maresin 1 (MaR1), is a potent immunoresolvent, stimulating resolution of acute inflammation and organ protection. Using an unbiased screening of greater than 200 GPCRs, we identified MaR1 as a stereoselective activator for human leucine-rich repeat containing G protein–coupled receptor 6 (LGR6), expressed in phagocytes. MaR1 specificity for recombinant human LGR6 activation was established using reporter cells expressing LGR6 and functional impedance sensing. MaR1-specific binding to LGR6 was confirmed using 3H-labeled MaR1. With human and mouse phagocytes, MaR1 (0.01–10 nM) enhanced phagocytosis, efferocytosis, and phosphorylation of a panel of proteins including the ERK and cAMP response element-binding protein. These MaR1 actions were significantly amplified with LGR6 overexpression and diminished by gene silencing in phagocytes. Thus, we provide evidence for MaR1 as an endogenous activator of human LGR6 and a novel role of LGR6 in stimulating MaR1’s key proresolving functions of phagocytes.
    [Show full text]
  • Inhibition of Δ24-Dehydrocholesterol Reductase Activates Pro-Resolving Lipid Mediator Biosynthesis and Inflammation Resolution
    Inhibition of Δ24-dehydrocholesterol reductase activates pro-resolving lipid mediator biosynthesis and inflammation resolution Andreas Körnera, Enchen Zhoub, Christoph Müllerc, Yassene Mohammedd, Sandra Hercegc, Franz Bracherc, Patrick C. N. Rensenb, Yanan Wangb, Valbona Mirakaja, and Martin Gierad,1 aDepartment of Anesthesiology and Intensive Care Medicine, Molecular Intensive Care Medicine, Eberhard Karls University Tübingen, 72072 Tübingen, Germany; bDepartment of Medicine, Division of Endocrinology, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333ZA Leiden, The Netherlands; cDepartment of Pharmacy-Center for Drug Research, Ludwig Maximilians University Munich, 81377 Munich, Germany; and dCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2333ZA Leiden, The Netherlands Edited by Christopher K. Glass, University of California San Diego, La Jolla, CA, and approved September 3, 2019 (received for review July 27, 2019) Targeting metabolism through bioactive key metabolites is an desmosterol to cholesterol (Fig. 1A). Of the 10 enzymes involved in upcoming future therapeutic strategy. We questioned how modi- distal cholesterol biosynthesis, starting with squalene, DHCR24 has fying intracellular lipid metabolism could be a possible means for recently taken center stage in several diseases. This enzyme has been alleviating inflammation. Using a recently developed chemical probe linked to Alzheimer’s disease (AD), oncogenic and oxidative stress (SH42), we inhibited distal cholesterol biosynthesis through selective (10), hepatitis C virus (HCV) infections (11), differentiation of T 24 inhibition of Δ -dehydrocholesterol reductase (DHCR24). Inhibition helper-17 cells (12), development of foam cells (13), and prostate of DHCR24 led to an antiinflammatory/proresolving phenotype in a cancer (14). While the role of DHCR24 in AD is controversially murine peritonitis model.
    [Show full text]
  • Eicosanoids and Exosomes: a Link Between Macrophages and Lung Cancer
    From MEDICAL BIOCHEMISTRY AND BIOPHYSICS DEPARTMENT Karolinska Institutet, Stockholm, Sweden EICOSANOIDS AND EXOSOMES: A LINK BETWEEN MACROPHAGES AND LUNG CANCER Ana Lukic Stockholm 2017 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by E-print AB 2017 © Ana Lukic, 2017 ISBN 978-91-7676-849-5 Eicosanoids and exosomes: a link between macrophages and lung cancer THESIS FOR DOCTORAL DEGREE (Ph.D.) Public defense at Karolinska Institutet, Samuelssonssalen, Tomtebodavägen 6, Solna. Thursday November 23rd 2017, at 13:00. By Ana Lukic Principal Supervisor: Opponent: Prof. Olof Rådmark Prof. Anita Sjölander Karolinska Institutet Lund University Department of Medical Biochemistry and Department of Translational Medicine Biophysics Division of Chemistry II Examination Board: Prof. Jonas Fuxe Co-supervisor(s): Karolinska Institute Prof. Susanne Gabrielsson Department of Microbiology, Tumor and Cell Karolinska Institute Biology Department of Medicine Immunology and Allergy Unit Prof. Mikael Adner Karolinska Institute Prof. Bengt Samuelsson Department of Environmental Medicine Karolinska Institutet Department of Medical Biochemistry and Prof. Esbjörn Telemo Biophysics University of Gothenburg Division of Chemistry II Department of Rheumatology and Inflammation Research A Marco ABSTRACT Chronic inflammation increases the risk of lung cancer. Macrophages (MO) are important players in inflammation, with regulatory and executive functions. Eicosanoids and exosomes can be both triggers and mediators of these functions. Cysteinyl leukotrienes (CysLTs) are the most potent mediators of broncho-constriction in the lungs, a function exerted via CysLT1 receptor. Their function in asthma is well described, but little is known about CysLTs and lung cancer. In the first study we investigated how the interaction between pulmonary epithelium and leukocytes affects CysLTs formation.
    [Show full text]